Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises
Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associa...
Gespeichert in:
| Veröffentlicht in: | Trends in molecular medicine 2015-10, Vol.21 (10), p.633-644 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 644 |
|---|---|
| container_issue | 10 |
| container_start_page | 633 |
| container_title | Trends in molecular medicine |
| container_volume | 21 |
| creator | Boots, Agnes W Bos, Lieuwe D van der Schee, Marc P van Schooten, Frederik-Jan Sterk, Peter J |
| description | Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes. After recent proof of concept studies demonstrating moderate to good diagnostic accuracies, the latest efforts in breathomics are focused on optimization of sensor technologies and analytical algorithms, as well as on independent validation of clinical classification and prediction. Current research strategies are revealing the underlying pathophysiological pathways as well as clinically-acceptable levels of diagnostic accuracy. Implementing recent guidelines on validating molecular signatures in medicine will enhance the clinical potential of breathomics and the development of point-of-care technologies. |
| doi_str_mv | 10.1016/j.molmed.2015.08.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1718912291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1471491415001574</els_id><sourcerecordid>1718912291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-ab26a25a2316d7af38f4a42ba036daee14505a50a0790915e9d22cd342aa218f3</originalsourceid><addsrcrecordid>eNqFkU1vFDEMhiMEoqX0HyA0Ry47jTOZrx6QUD8oUlGRgKriEnkTz5JtNmmTmar992S6LQcunPxKfmzL78vYO-AlcGgO1uUmuA2ZUnCoS96VnMMLtguyhYXs-6uXfzXIHfYmpXUG6rbtXrMd0chKcMF32a-T-9_oyBRfgyM9OYzFqfUrijfR-jGrwvri2OLKh2RTgX4mvR1Dbq8Oi0t01uAjdxlcFo6KbzFsbKL0lr0a0CXaf6p77OfpyY-js8X5xecvR5_OF1pCOy5wKRoUNYoKGtPiUHWDRCmWyKvGIBHImtdYc-Rtz3uoqTdCaFNJgSigG6o99mG79yaG24nSqPJ5Tc6hpzAlBS10PQjRQ0blFtUxpBRpUPnNDcYHBVzNrqq12rqqZlcV71Q2LY-9f7owLefe89CzjRn4uAUo_3lnKaqkLXlNxkbSozLB_u_Cvwu0s95qdNf0QGkdpuizhwpUEoqr73Oyc7BQP4Yqqz_yJZ-u</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718912291</pqid></control><display><type>article</type><title>Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Boots, Agnes W ; Bos, Lieuwe D ; van der Schee, Marc P ; van Schooten, Frederik-Jan ; Sterk, Peter J</creator><creatorcontrib>Boots, Agnes W ; Bos, Lieuwe D ; van der Schee, Marc P ; van Schooten, Frederik-Jan ; Sterk, Peter J</creatorcontrib><description>Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes. After recent proof of concept studies demonstrating moderate to good diagnostic accuracies, the latest efforts in breathomics are focused on optimization of sensor technologies and analytical algorithms, as well as on independent validation of clinical classification and prediction. Current research strategies are revealing the underlying pathophysiological pathways as well as clinically-acceptable levels of diagnostic accuracy. Implementing recent guidelines on validating molecular signatures in medicine will enhance the clinical potential of breathomics and the development of point-of-care technologies.</description><identifier>ISSN: 1471-4914</identifier><identifier>EISSN: 1471-499X</identifier><identifier>DOI: 10.1016/j.molmed.2015.08.001</identifier><identifier>PMID: 26432020</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Biomarkers ; Breath ; diagnosis ; eNose ; Exhalation ; GC-MS ; Humans ; Metabolomics ; Molecular Diagnostic Techniques ; Pathology ; Respiration Disorders - diagnosis ; Volatile Organic Compounds</subject><ispartof>Trends in molecular medicine, 2015-10, Vol.21 (10), p.633-644</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-ab26a25a2316d7af38f4a42ba036daee14505a50a0790915e9d22cd342aa218f3</citedby><cites>FETCH-LOGICAL-c417t-ab26a25a2316d7af38f4a42ba036daee14505a50a0790915e9d22cd342aa218f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molmed.2015.08.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26432020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boots, Agnes W</creatorcontrib><creatorcontrib>Bos, Lieuwe D</creatorcontrib><creatorcontrib>van der Schee, Marc P</creatorcontrib><creatorcontrib>van Schooten, Frederik-Jan</creatorcontrib><creatorcontrib>Sterk, Peter J</creatorcontrib><title>Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises</title><title>Trends in molecular medicine</title><addtitle>Trends Mol Med</addtitle><description>Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes. After recent proof of concept studies demonstrating moderate to good diagnostic accuracies, the latest efforts in breathomics are focused on optimization of sensor technologies and analytical algorithms, as well as on independent validation of clinical classification and prediction. Current research strategies are revealing the underlying pathophysiological pathways as well as clinically-acceptable levels of diagnostic accuracy. Implementing recent guidelines on validating molecular signatures in medicine will enhance the clinical potential of breathomics and the development of point-of-care technologies.</description><subject>Animals</subject><subject>Biomarkers</subject><subject>Breath</subject><subject>diagnosis</subject><subject>eNose</subject><subject>Exhalation</subject><subject>GC-MS</subject><subject>Humans</subject><subject>Metabolomics</subject><subject>Molecular Diagnostic Techniques</subject><subject>Pathology</subject><subject>Respiration Disorders - diagnosis</subject><subject>Volatile Organic Compounds</subject><issn>1471-4914</issn><issn>1471-499X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1vFDEMhiMEoqX0HyA0Ry47jTOZrx6QUD8oUlGRgKriEnkTz5JtNmmTmar992S6LQcunPxKfmzL78vYO-AlcGgO1uUmuA2ZUnCoS96VnMMLtguyhYXs-6uXfzXIHfYmpXUG6rbtXrMd0chKcMF32a-T-9_oyBRfgyM9OYzFqfUrijfR-jGrwvri2OLKh2RTgX4mvR1Dbq8Oi0t01uAjdxlcFo6KbzFsbKL0lr0a0CXaf6p77OfpyY-js8X5xecvR5_OF1pCOy5wKRoUNYoKGtPiUHWDRCmWyKvGIBHImtdYc-Rtz3uoqTdCaFNJgSigG6o99mG79yaG24nSqPJ5Tc6hpzAlBS10PQjRQ0blFtUxpBRpUPnNDcYHBVzNrqq12rqqZlcV71Q2LY-9f7owLefe89CzjRn4uAUo_3lnKaqkLXlNxkbSozLB_u_Cvwu0s95qdNf0QGkdpuizhwpUEoqr73Oyc7BQP4Yqqz_yJZ-u</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Boots, Agnes W</creator><creator>Bos, Lieuwe D</creator><creator>van der Schee, Marc P</creator><creator>van Schooten, Frederik-Jan</creator><creator>Sterk, Peter J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151001</creationdate><title>Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises</title><author>Boots, Agnes W ; Bos, Lieuwe D ; van der Schee, Marc P ; van Schooten, Frederik-Jan ; Sterk, Peter J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-ab26a25a2316d7af38f4a42ba036daee14505a50a0790915e9d22cd342aa218f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Biomarkers</topic><topic>Breath</topic><topic>diagnosis</topic><topic>eNose</topic><topic>Exhalation</topic><topic>GC-MS</topic><topic>Humans</topic><topic>Metabolomics</topic><topic>Molecular Diagnostic Techniques</topic><topic>Pathology</topic><topic>Respiration Disorders - diagnosis</topic><topic>Volatile Organic Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boots, Agnes W</creatorcontrib><creatorcontrib>Bos, Lieuwe D</creatorcontrib><creatorcontrib>van der Schee, Marc P</creatorcontrib><creatorcontrib>van Schooten, Frederik-Jan</creatorcontrib><creatorcontrib>Sterk, Peter J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boots, Agnes W</au><au>Bos, Lieuwe D</au><au>van der Schee, Marc P</au><au>van Schooten, Frederik-Jan</au><au>Sterk, Peter J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises</atitle><jtitle>Trends in molecular medicine</jtitle><addtitle>Trends Mol Med</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>21</volume><issue>10</issue><spage>633</spage><epage>644</epage><pages>633-644</pages><issn>1471-4914</issn><eissn>1471-499X</eissn><abstract>Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes. After recent proof of concept studies demonstrating moderate to good diagnostic accuracies, the latest efforts in breathomics are focused on optimization of sensor technologies and analytical algorithms, as well as on independent validation of clinical classification and prediction. Current research strategies are revealing the underlying pathophysiological pathways as well as clinically-acceptable levels of diagnostic accuracy. Implementing recent guidelines on validating molecular signatures in medicine will enhance the clinical potential of breathomics and the development of point-of-care technologies.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26432020</pmid><doi>10.1016/j.molmed.2015.08.001</doi><tpages>12</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-4914 |
| ispartof | Trends in molecular medicine, 2015-10, Vol.21 (10), p.633-644 |
| issn | 1471-4914 1471-499X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1718912291 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Animals Biomarkers Breath diagnosis eNose Exhalation GC-MS Humans Metabolomics Molecular Diagnostic Techniques Pathology Respiration Disorders - diagnosis Volatile Organic Compounds |
| title | Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T23%3A06%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exhaled%20Molecular%20Fingerprinting%20in%20Diagnosis%20and%20Monitoring:%20Validating%20Volatile%20Promises&rft.jtitle=Trends%20in%20molecular%20medicine&rft.au=Boots,%20Agnes%20W&rft.date=2015-10-01&rft.volume=21&rft.issue=10&rft.spage=633&rft.epage=644&rft.pages=633-644&rft.issn=1471-4914&rft.eissn=1471-499X&rft_id=info:doi/10.1016/j.molmed.2015.08.001&rft_dat=%3Cproquest_cross%3E1718912291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1718912291&rft_id=info:pmid/26432020&rft_els_id=1_s2_0_S1471491415001574&rfr_iscdi=true |